Skip to content

Andrew Guggenhime, President and CFO at Vaxcyte, sold PCVX on Aug 3, 2026

Data as of Oct 16

▼ SELL$374K6,956 shares at $53.76Andrew Guggenhime President and CFOPCVX Vaxcyte, Inc.
Watch PCVX
Traded
Aug 3, 2026
Disclosed
Aug 5, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Andrew Guggenhime, President and CFO at Vaxcyte, sold PCVX on Aug 3, 2026TRADEDDISCLOSED
PCVXSimilar stocks (XLV — its sector index fund), rebased to PCVX's price on the disclosure day
PCVX since disclosure
+13.8%
after the sale
Similar stocks (XLV) since disclosure
+7.6%
XLV — its sector index fund

Change in closing price from Aug 5, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLAndrew Guggenhime President and CFOPCVX Vaxcyte, Inc.$165Kdisclosed Aug 5 · filed 2 days after the trade

See every trade on PCVX →